Tick-borne diseases are spreading into new parts of the United States at a pace that has caught public health officials off guard. Babesiosis, a potentially fatal parasitic infection once confined to a handful of Northeastern states, is now appearing in regions where it was previously unknown. At the same time, Rocky Mountain spotted fever continues to kill patients who do not receive timely treatment, and a growing number of clinicians lack the training to recognize these illnesses before they turn severe.
Babesiosis Pushes Beyond Its Traditional Boundaries
For decades, babesiosis was treated as a regional problem. The disease, caused by parasites that destroy red blood cells, has long been concentrated in the Northeast and the Upper Midwest. But that geographic comfort zone is shrinking. A CDC national surveillance analysis covering 2011 through 2019 documented significant incidence increases and expansion of endemic transmission into new geographies during that period. The numbers from Northern New England tell the story most sharply: Vermont reported just 2 babesiosis cases in 2011, climbing to 34 by 2019. Maine saw an even steeper rise, from 9 cases to 138 over the same window.
Those increases are not simply the result of better testing or reporting. The University of Nebraska Medical Center noted that while babesiosis typically occurs in the Northeast and the Upper Midwest, new research suggests rare cases are emerging in other parts of America. That shift matters because babesiosis can be life-threatening for older adults, people without a spleen, and those with weakened immune systems. When the disease appears in areas where doctors have little experience diagnosing it, the risk of delayed treatment rises considerably.
Researchers and clinicians also emphasize that babesiosis does not exist in isolation. The same blacklegged ticks that transmit Babesia parasites also carry Lyme disease and anaplasmosis, creating a growing burden of co-infections. A separate discussion in the Nebraska report, drawing on coverage from Smithsonian-linked reporting, underscores how climate shifts and changing land use are helping ticks thrive in places that were once too cold or too dry. As habitats change, the line between “endemic” and “emerging” risk becomes harder to draw.
Rocky Mountain Spotted Fever Remains a Persistent Killer
Babesiosis is not the only tick-borne threat gaining ground. Rocky Mountain spotted fever (RMSF), transmitted primarily by the brown dog tick in parts of the Americas, remains endemic across large areas and continues to produce severe and fatal outcomes. A CDC MMWR report published in late 2024 highlighted the persistent high incidence of the disease and the consequences of delayed diagnosis and treatment.
The danger is not theoretical. A deadly cluster tied to a city in Mexico illustrated how quickly RMSF can kill. At least five people contracted the disease, all five were hospitalized, and three of them died. The CDC has issued travel health notices warning that illness and death due to RMSF have been reported in the northern region of Mexico, a concern for Americans crossing the border into affected areas. RMSF is treatable with the antibiotic doxycycline, but only when clinicians suspect it early enough. A delay of even a few days can mean the difference between recovery and organ failure.
Unlike some other tick-borne infections, RMSF often begins with nonspecific symptoms such as fever, headache, and muscle aches, which can be mistaken for viral illnesses. The characteristic rash may appear late or not at all, especially in the earliest stages when treatment is most effective. The CDC has repeatedly stressed that clinicians in endemic and neighboring regions should initiate doxycycline as soon as RMSF is suspected, rather than waiting for confirmatory tests. Yet the Mexico outbreak shows how easily early warning signs can be missed when providers are unfamiliar with the disease or underestimate its severity.
Clinician Knowledge Gaps Compound the Threat
The expansion of tick-borne diseases into new regions collides with a separate problem: many health care providers are not prepared to recognize them. A CDC survey conducted from March to May 2022 found that many clinicians have limited familiarity with alpha-gal syndrome, a tick-bite-associated condition that can trigger severe allergic reactions to red meat and certain animal-derived products. Alpha-gal syndrome is distinct from infections like babesiosis or RMSF, but it shares the same diagnostic blind spot: doctors who have never encountered it may dismiss or misdiagnose the symptoms.
A separate CDC analysis estimated and mapped suspected alpha-gal syndrome cases using lab-test-based surveillance signals from January 2017 through December 2022. The results revealed suspected cases well beyond the Southern states where the condition was first identified, suggesting that the geographic footprint of tick-triggered illness is broader than clinical awareness has kept pace with. When providers in newly affected areas are unfamiliar with a condition, patients cycle through multiple appointments and emergency visits before getting an accurate diagnosis, if they get one at all.
These knowledge gaps are not limited to rare syndromes. Many clinicians receive only brief training on tick-borne diseases during medical school and residency, often focused on Lyme disease in historically high-incidence states. As cases of babesiosis, RMSF, and other infections appear in regions that previously saw few, local providers may not connect a summer fever or unexplained anemia to a tick bite that happened weeks earlier. Public health officials argue that continuing education, updated clinical guidelines, and better decision-support tools in electronic health records are essential to closing this gap.
Anaplasmosis Adds to the Surveillance Challenge
The list of expanding tick-borne diseases does not end with babesiosis and alpha-gal syndrome. Anaplasmosis, a bacterial infection spread by the same blacklegged ticks that carry Lyme disease, is most common in the Upper Midwest and Northeast and has become increasingly nationally notifiable, according to the CDC’s epidemiology data for the disease. The agency provides downloadable files for annual case counts through 2023, offering a clearer picture of how the disease has spread over time.
One wrinkle in interpreting these rising numbers is the evolving case definition itself. The 2024 case definition for anaplasmosis includes clinical criteria and confirmatory laboratory evidence such as PCR or NAAT detection. Improved diagnostics and broader surveillance naturally capture more cases. But that does not fully explain the trend. Environmental conditions, including warmer winters and expanding deer populations, have pushed tick habitats into areas where they were once rare. The result is that diseases like anaplasmosis now appear in counties and states that had little reason to suspect them a decade ago, complicating both clinical suspicion and public health planning.
National surveillance summaries from the CDC show that reported tick-borne infections overall have increased substantially over the past two decades, as reflected in surveillance data summaries that aggregate multiple pathogens. These compilations underscore how changing tick ranges, improved reporting, and heightened awareness all contribute to the numbers. Yet the steady upward trajectory across several diseases suggests that ecological and behavioral factors, such as more people living near wooded areas and spending time outdoors, are also driving real growth in risk.
Closing the Gap Between Risk and Readiness
Public health agencies and clinicians face a dual challenge: the biological reality of expanding tick habitats and pathogens, and the human reality of incomplete awareness and uneven access to care. Addressing that gap will require investments on several fronts. Surveillance systems need to remain flexible enough to detect emerging hotspots quickly, including places where tick-borne diseases have not historically been monitored closely. Training programs for physicians, nurse practitioners, and physician assistants must integrate up-to-date information about regional tick risks and emphasize early empiric treatment for severe infections like RMSF.
For patients, prevention still offers the most reliable protection. Using insect repellent, performing tick checks after outdoor activities, and promptly removing attached ticks can reduce the likelihood of infection, though no method is foolproof. As diseases such as babesiosis, anaplasmosis, and alpha-gal syndrome continue to appear in new areas, public health messaging will need to reach communities that have never considered ticks a serious threat. The growing body of surveillance and clinical research makes clear that tick-borne illnesses are no longer confined to a narrow band of states or a single well-known disease, and the health care system will have to adapt just as quickly as the ticks themselves.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
